Sources | Names Used |
---|---|
CTRPv2 | UNC0638:navitoclax (1:1 mol/mol) |
PharmacoGx | UNC0638:navitoclax (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-15 |
mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-15 |
mRNA | BEND5 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-15 |
mRNA | TMOD2 | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-15 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-15 |
mRNA | KIF5C | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-15 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.32 | 6e-15 |
mRNA | NEURL1B | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-15 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-15 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-15 |